lncRNA,%20mRNA,%20ESWL,PCNL,SBF2-AS1,%20FENDRR-19,%20NLRP3.
Showing 1 - 25 of >10,000
Acute Kidney Injury, Renal Calculi, Percutaneous Nephrolithotomy Trial in Cairo (Percutaneous nephrolithotomy, Extracorporeal
Recruiting
- Acute Kidney Injury
- +3 more
- Percutaneous nephrolithotomy
- Extracorporeal Shock Wave Lithotripsy
-
Cairo, EgyptUrology Department, Faculty of Medicine, Ain Shams University
Feb 18, 2022
Stone, Kidney Trial in Cairo (mini-PCNL procedure, RIRS procedure)
Completed
- Stone, Kidney
- mini-PCNL procedure
- RIRS procedure
-
Cairo, EgyptAbdelrahman Nazmy Abbas Hatata
Sep 2, 2023
Role of LncRNA H19 in The Regulation of IGF-1R Expression
Completed
- Hepatocellular Carcinoma
- +2 more
- Blood sample collection
-
Mansoura, Dakahliya, Egypt
- +1 more
Apr 5, 2022
Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain
Recruiting
- Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
- Quantitative Real Time Polymerase chain reaction (qRT-PCR)
- ELISA and colorimeter
-
Assiut, EgyptBiochemistry department,Faculty of medicine
Oct 10, 2023
Covid19, Cytokine Release Syndrome Trial in Netherlands, Switzerland, United States (dapansutrile capsules, capsules)
Recruiting
- Covid19
- Cytokine Release Syndrome
- dapansutrile capsules
- placebo capsules
-
Denver, Colorado
- +13 more
Sep 16, 2022
Severe Obesity Trial in Fort-de-France (Standardized physical activity protocol associated with the consumption of Cajanus cajan
Not yet recruiting
- Severe Obesity
- Standardized physical activity protocol associated with the consumption of Cajanus cajan (EXACAJAN)
-
Fort-de-France, MartiniqueCHU de Martinique
Aug 8, 2022
Extracorporeal Shock Wave Lithotripsy for Pancreatic Stones
Recruiting
- Pancreatic Duct Stone
- pancreatic extracorporeal shock wave lithotripsy
-
Shanghai, ChinaChanghai Hospital
Jun 27, 2023
SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)
Recruiting
- SARS-CoV-2 Infection
- COVID-19 mRNA Vaccine (ZSVG-02-O)
- COVID-19 Vaccine (Vero Cell) ,Inactivated
-
Dengfeng, Henan, China
- +1 more
Nov 6, 2023
lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome
Enrolling by invitation
- Acute Respiratory Distress Syndrome
- Inflammation
- no intervention
-
Beijing, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, Beijing An
Jun 16, 2021
Early Disease Onset Trial (Puva (psoralin and uva ))
Not yet recruiting
- Early Disease Onset
- Puva (psoralin and uva )
- (no location specified)
Sep 27, 2023
COVID-19 Trial in Kunming (RQ3013, RQ3025, RQ3027)
Recruiting
- COVID-19
- RQ3013
- +2 more
-
Kunming, Yunnan, ChinaThe Affiliated Hospital of Yunnan University
Jun 22, 2023
SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273.211
- +6 more
-
Sacramento, California
- +22 more
Nov 16, 2022
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
Healthy Trial in Ahmedabad (ZYIL1 Capsule)
Completed
- Healthy
- ZYIL1 Capsule
-
Ahmedabad, Gujarat, IndiaZydus Research Centre
Nov 15, 2021
SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10
Recruiting
- SARS-CoV-2 Infection
- Placebo
- +4 more
-
Hangzhou, Zhejiang, ChinaShulan (Hangzhou) Hospital
Nov 7, 2023
SARS-CoV-2 Trial in United States (mRNA-1273, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273
- +2 more
-
Banning, California
- +48 more
Jan 5, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
COVID-19 Infection Trial in Turkey (Taking biological samples (blood) and keeping records with phone calls)
Active, not recruiting
- COVID-19 Infection
- Taking biological samples (blood) and keeping records with phone calls
-
Ankara, Turkey
- +7 more
May 16, 2023
PCNL Trial (laparoscopic trocar 12mm)
Not yet recruiting
- PCNL
- laparoscopic trocar 12mm
- (no location specified)
Jan 22, 2023
COVID-19 Trial in Melbourne (Bivalent Moderna, Novavax)
Not yet recruiting
- COVID-19
- Bivalent Moderna
- Novavax
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital, Murdoch Children's Research Institute
Jan 23, 2023
Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine
Recruiting
- Influenza, Human
- COVID-19
- Comirnaty
- Quadrivalent Influenza Vaccine
-
New York, New YorkPfizer
May 11, 2023
SARS-CoV-2 Trial (CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose)
Not yet recruiting
- SARS-CoV-2
- CV0701 Bivalent High dose
- +4 more
- (no location specified)
Jul 24, 2023
Renal Stone Trial in Cairo (Endoscopic combined intrarenal surgery, Percutaneous nephrolithotomy)
Recruiting
- Renal Stone
- Endoscopic combined intrarenal surgery
- Percutaneous nephrolithotomy
-
Cairo, EgyptAin Shams University Hospitals
Oct 10, 2023
Nephrolithotomy, Percutaneous, Kidney Calculi Trial in Hengyang (without reverse ureteral catheter insertion)
Recruiting
- Nephrolithotomy, Percutaneous
- Kidney Calculi
- without reverse ureteral catheter insertion
-
Hengyang, Hunan, ChinaThe First Affiliated Hospital of University of South China
Nov 6, 2022